{
  "ptid_time": "130_S_4925_2012-12-19",
  "img_path": "/data/qiuhui/data/adni/images/130_S_4925/2012-12-19/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 76,958 mm³, 99.8% above the reference mean. With a Z-score of 2.39 (99.2th percentile), this represents significant enlargement; hippocampal volume measures 6,594 mm³, 12.8% below the reference mean. With a Z-score of -1.25 (10.6th percentile), this represents mild atrophy; whole brain volume measures 1,078,710 mm³, 0.1% below the reference mean. With a Z-score of -0.01 (49.7th percentile), this represents normal volume ; entorhinal cortex volume measures 4,165 mm³, 1.6% above the reference mean. With a Z-score of 0.11 (54.2th percentile), this represents normal volume ; fusiform gyrus volume measures 18,059 mm³, 4.1% below the reference mean. With a Z-score of -0.35 (36.2th percentile), this represents normal volume ; middle temporal gyrus volume measures 19,468 mm³, 8.8% below the reference mean. With a Z-score of -0.79 (21.5th percentile), this represents normal volume . ",
  "text_data": "Age is 75.0 years. Gender is Male. Education: 12 years. Handedness: Right. Race: White. Medical history: Psychiatric; Neurologic; Cardiovascular; Respiratory; Endocrine-Metabolic; Gastrointestinal; Renal-Genitourinary; Major Surgical Procedures. MMSE: 27.0. MoCA: 18.0. Logical Memory: 4.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.79 SUVR (profound elevated); Amyloid beta: 694.00 pg/mL (normal ); Total tau: 250.70 pg/mL (normal ); Phosphorylated tau: 27.16 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The data shows significant ventricular enlargement (suggesting atrophy) and mild hippocampal atrophy, which are structural changes often seen in neurodegenerative conditions. However, the MMSE is normal (27/30), while the MoCA is impaired (18/30), indicating possible cognitive deficits. Biomarkers (Aβ, T-tau, P-tau) are normal, but AV45 (amyloid PET) is profoundly elevated, suggesting amyloid pathology despite normal CSF markers.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (due to structural atrophy, MoCA impairment, and amyloid positivity, but preserved MMSE and no clear functional decline for dementia).  \n\n**Confidence:** **Medium** (conflicting biomarkers and cognitive scores complicate the diagnosis; amyloid PET suggests Alzheimer’s pathology, but CSF is normal, and clinical presentation is not yet dementia).",
  "timestamp": "2025-07-26T14:53:42.960306"
}